CN105125909A - 一种治疗小儿疱疹性咽颊炎的中药口服液及其制备方法 - Google Patents
一种治疗小儿疱疹性咽颊炎的中药口服液及其制备方法 Download PDFInfo
- Publication number
- CN105125909A CN105125909A CN201510551141.7A CN201510551141A CN105125909A CN 105125909 A CN105125909 A CN 105125909A CN 201510551141 A CN201510551141 A CN 201510551141A CN 105125909 A CN105125909 A CN 105125909A
- Authority
- CN
- China
- Prior art keywords
- radix
- oral liquid
- chinese medicine
- herpangina
- children
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 29
- 239000003814 drug Substances 0.000 title claims abstract description 23
- 201000006219 Herpangina Diseases 0.000 title claims abstract description 17
- 238000000034 method Methods 0.000 title claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 30
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims abstract description 15
- 210000000582 semen Anatomy 0.000 claims abstract description 13
- 229930006000 Sucrose Natural products 0.000 claims abstract description 12
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 12
- 239000005720 sucrose Substances 0.000 claims abstract description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 25
- 230000002421 anti-septic effect Effects 0.000 claims description 15
- 238000003756 stirring Methods 0.000 claims description 15
- 241000628997 Flos Species 0.000 claims description 12
- 239000010231 banlangen Substances 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 10
- 239000011259 mixed solution Substances 0.000 claims description 10
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000012467 final product Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 238000004064 recycling Methods 0.000 claims description 5
- 239000000243 solution Substances 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 4
- 229940126678 chinese medicines Drugs 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 13
- 239000000463 material Substances 0.000 abstract 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 abstract 2
- 244000001632 Acorus gramineus Species 0.000 abstract 1
- 235000013073 Acorus gramineus Nutrition 0.000 abstract 1
- 244000236521 Bupleurum rotundifolium Species 0.000 abstract 1
- 235000015221 Bupleurum rotundifolium Nutrition 0.000 abstract 1
- 241000245240 Lonicera Species 0.000 abstract 1
- 241001570521 Lonicera periclymenum Species 0.000 abstract 1
- 235000006751 Platycodon Nutrition 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 244000185386 Thladiantha grosvenorii Species 0.000 abstract 1
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 abstract 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 abstract 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 abstract 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 abstract 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 abstract 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 abstract 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 abstract 1
- 229960002216 methylparaben Drugs 0.000 abstract 1
- 229930189914 platycodon Natural products 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 10
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 9
- 230000008961 swelling Effects 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 206010037660 Pyrexia Diseases 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 206010019233 Headaches Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 206010039424 Salivary hypersecretion Diseases 0.000 description 5
- 208000008630 Sialorrhea Diseases 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 210000003026 hypopharynx Anatomy 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 208000015220 Febrile disease Diseases 0.000 description 4
- 206010042674 Swelling Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- BWMPANCYUOEPFB-UHFFFAOYSA-N 5-phenyl-5-piperidin-1-yl-1,3-bis(2-piperidin-1-ylethyl)-1,3-diazinane-2,4,6-trione Chemical compound O=C1C(N2CCCCC2)(C=2C=CC=CC=2)C(=O)N(CCN2CCCCC2)C(=O)N1CCN1CCCCC1 BWMPANCYUOEPFB-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 108010074051 C-Reactive Protein Proteins 0.000 description 1
- 102100032752 C-reactive protein Human genes 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 201000006082 Chickenpox Diseases 0.000 description 1
- 206010008531 Chills Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 241000709687 Coxsackievirus Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010016322 Feeling abnormal Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010018045 Gastroptosis Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010039587 Scarlet Fever Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 206010046980 Varicella Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 238000005899 aromatization reaction Methods 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QYIYFLOTGYLRGG-GPCCPHFNSA-N cefaclor Chemical compound C1([C@H](C(=O)N[C@@H]2C(N3C(=C(Cl)CS[C@@H]32)C(O)=O)=O)N)=CC=CC=C1 QYIYFLOTGYLRGG-GPCCPHFNSA-N 0.000 description 1
- 229960005361 cefaclor Drugs 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000009438 liyan Substances 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 229960000329 ribavirin Drugs 0.000 description 1
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000001584 soft palate Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供一种治疗小儿疱疹性咽颊炎的中药口服液及其制备方法,所述口服液由100-120g板蓝根、100-120g石膏、50-80g芦根、80-100g地黄、150-160g石菖蒲、100-120g广藿香、60-80g连翘、20-30g忍冬藤、100-120g白芷,80-100g胖大海、60-80g蒲公英、80-100g罗汉果、100-120g金银花、50-60g桔梗、30-60g葛根、50-60g荆芥、10-15g川贝、60-80g甘草、50-60g柴胡、10-20g防风、30-60g蔗糖、1-5g防腐剂加入水中制成;防腐剂为羟苯甲腊或羟苯乙脂。本发明用药量小、见效快、无副作用。
Description
技术领域
本发明涉及一种治疗小儿疱疹性咽颊炎的中药口服液及其制备方法。
背景技术
疱疹性咽峡炎是儿童最易得的疾病,由许多A组柯萨奇病毒(偶尔也有其他肠道病毒)所引起,其特点为疱疹性溃疡性粘膜损害。疱疹性咽峡炎起病非常急,头天玩得挺好,第二天就高烧不退,咽部出现疱疹。一般的儿童患病后,常表现为高热、咽痛、流涎、厌食、呕吐、咽部充血,并出现数个至数十个2~4毫米的灰白色疱疹,周围伴有红晕。一般一两天后疱疹就开始破溃成小溃疡,孩子非常难受。临床建议参考用药:利巴维林、尼美舒、希刻劳等抗生素药品,用药至少一周才能有所缓解。
发明内容
本发明为了克服现有技术中采用抗生素治疗小儿疱疹性咽颊炎疗效差、时间长的缺点,提供一种用药量小、见效快、无副作用的中药口服液及其制备方法。
一种治疗小儿疱疹性咽颊炎的中药口服液,由100-120g板蓝根、100-120g石膏、50-80g芦根、80-100g地黄、150-160g石菖蒲、100-120g广藿香、60-80g连翘、20-30g忍冬藤、100-120g白芷,80-100g胖大海、60-80g蒲公英、80-100g罗汉果、100-120g金银花、50-60g桔梗、30-60g葛根、50-60g荆芥、10-15g川贝、60-80g甘草、50-60g柴胡、10-20g防风、30-60g蔗糖、1-5g防腐剂加入水中制成;防腐剂为羟苯甲腊或羟苯乙脂。
优选的是:由100g板蓝根、100g石膏、80g芦根、100g地黄、150g石菖蒲、100g广藿香、80g连翘、20g忍冬藤、120g白芷,80g胖大海、60g蒲公英、100g罗汉果、120g金银花、50g桔梗、30g葛根、60g荆芥、10g川贝、80g甘草、50g柴胡、10g防风、60g蔗糖、5g防腐剂加入水中制成。
优选的是:由120g板蓝根、120g石膏、50g芦根、80g地黄、160g石菖蒲、100g广藿香、60g连翘、30g忍冬藤、100g白芷,80g胖大海、80g蒲公英、80g罗汉果、100g金银花、60g桔梗、60g葛根、50g荆芥、15g川贝、60g甘草、60g柴胡、20g防风、30g蔗糖、1g防腐剂加入水中制成。
优选的是:由110g板蓝根、110g石膏、60g芦根、90g地黄、150g石菖蒲、110g广藿香、70g连翘、25g忍冬藤、110g白芷,90g胖大海、7g蒲公英、9g罗汉果、11g金银花、55g桔梗、50g葛根、55荆芥、10g川贝、7g甘草、55g柴胡、15g防风、50g蔗糖、3g防腐剂加入水中制成。
本发明还提供制备上述中药口服液的方法,包括如下步骤:
1)将石膏用水煎煮0.5h,然后加入其他中药再用水煎煮3次,每次1h,而后合并煎液,得混合煎液;
2)将混合煎液过滤,而后减压浓缩至80℃的条件下的相对密度为1.10~1.15的清膏,自然冷却至室温,加入乙醇至溶液中含醇量为70%~80%,而后搅拌均匀,再静置20~30h,得混合溶液;
3)将混合溶液过滤,滤液回收乙醇并浓缩至80℃的条件下的相对密度为1.20~1.25的清膏,然后加水至1800~2000mL,搅拌均匀,在温度为4~7℃的条件下冷藏处理90~100h,过滤,滤液加入防腐剂和糖,然后加水至1800~2000mL,搅拌均匀,即得。
本发明的治疗小儿疱疹性咽颊炎用中药口服液,具有清热凉血、泻火解毒之功效,各中药无任何毒副作用。
板蓝根,清热,解毒,凉血,利咽;主治风热感冒,流感,乙脑,大头瘟疫,烂喉丹痧,丹毒,咽喉肿痛,黄疸,水痘,麻疹。
石膏,辛甘大寒,主入肺胃气分,善清阳明气分大热,清热而不伤阴,并能止渴除烦。
芦根,味甘,性寒,归肺、胃经。具有清热泻火,生津止渴,止呕利尿之功效。
地黄,甘、苦,寒。归心、肝、肾经。清热生津,凉血,止血。用于热病伤阴,舌绛烦渴,发斑发疹,吐血,衄血,咽喉肿痛。
石菖蒲,辛、苦,温。归心、胃经。化湿开胃,开窍豁痰,醒神益智。用于脘痞不饥,噤口下痢,神昏癫痫,健忘耳聋。
广藿香,味辛性微温无毒,归脾胃肺三经。具有:芳香化温、和中止呕、宣散表邪,行气化滞的作用。
连翘,味苦性微寒、归肺心小肠经、具有清热解毒、消肿散结。主治风热感冒、温病、痛疽肿毒。
忍冬藤,味甘、性微寒,具有清热解毒,疏风通络功能、主治温病发热、热毒血痢等症。
白芷,祛风除湿,通窍止痛,消肿排脓;主感冒头痛,眉棱骨痛,牙痛,鼻塞,鼻渊,湿胜久泻,赤白带下,痈疽疮疡。
胖大海,甘,寒,归肺、大肠经,能够清热润肺,利咽解毒。
蒲公英,味甘、微苦,性平;归肝、胃经。具有清热解毒,消肿散结,行水利尿之功效。
罗汉果,甘,凉,归肺、大肠经,能够清热润肺。
金银花,清热解毒;主温病发热,热毒血痢,痈肿疔疮,喉痹及多种感染性疾病。
桔梗,宣肺祛痰,利咽排脓;主治咳嗽痰多,咽喉肿痛,肺痈吐脓,胸满胁痛,痢疾腹痛,小便癃闭。
葛根,性味:性凉、味甘、辛,具有解表退热、生津、透疹、升阳止泻之功效,用于治疗外感发热头痛、高血压颈项强痛、口渴、消渴、麻疹不透、热痢、泄泻。
荆芥,性味:辛,温,具有发表、祛风、理血、炒炭止血之功效,用于治疗感冒发热、头痛、咽喉肿痛、中风口噤、吐血、衄血、便血、崩漏、产后血晕、痈肿、疮疥、瘰疬。
川贝,味甘、平,性凉;归肺经、胃经。具有润肺止咳,化痰平喘,清热化痰之功效。
甘草,和中缓急,润肺,解毒,调和诸药。炙用治脾胃虚弱,倦怠食少,腹痛便溏,四肢挛急疼痛,心悸,脏躁,肺痿咳嗽,生用治咽喉肿痛,痈疮肿痛,小儿胎毒,及药物、食物中毒。
柴胡,解表退热,疏肝解郁,升举阳气;主治外感发热,寒热往来,疟疾,肝郁胁痛乳胀,头痛头眩,月经不调,气虚下陷之脱肛,子宫脱垂,胃下垂。
防风,祛风解表,胜湿止痛,止痉,止痒;主外感风寒,偏正头痛,风湿痹痛,腹痛泄泻,肠风下血,破伤风,小儿惊风,风疹瘙痒,疮疡初起。
具体实施方式
实施例1:
1)将100g石膏用水煎煮0.5h,然后加入100g板蓝根、80g芦根、100g地黄、150g石菖蒲、100g广藿香、80g连翘、20g忍冬藤、120g白芷,80g胖大海、60g蒲公英、100g罗汉果、120g金银花、50g桔梗、30g葛根、60g荆芥、10g川贝、80g甘草、50g柴胡、10g防风再用水煎煮3次,每次1h,而后合并煎液,得混合煎液;
2)将混合煎液过滤,而后减压浓缩至80℃的条件下的相对密度为1.10~1.15的清膏,自然冷却至室温,加入乙醇至溶液中含醇量为70%~80%,而后搅拌均匀,再静置20~30h,得混合溶液;
3)将混合溶液过滤,滤液回收乙醇并浓缩至80℃的条件下的相对密度为1.20~1.25的清膏,然后加水至1800~2000mL,搅拌均匀,在温度为4~7℃的条件下冷藏处理90~100h,过滤,滤液加入60g蔗糖、5g防腐剂,然后加水至1800~2000mL,搅拌均匀,即得。
实施例2:
1)将120g石膏用水煎煮0.5h,然后加入120g板蓝根、50g芦根、80g地黄、160g石菖蒲、100g广藿香、60g连翘、30g忍冬藤、100g白芷,80g胖大海、80g蒲公英、80g罗汉果、100g金银花、60g桔梗、60g葛根、50g荆芥、15g川贝、60g甘草、60g柴胡、20g防风再用水煎煮3次,每次1h,而后合并煎液,得混合煎液;
2)将混合煎液过滤,而后减压浓缩至80℃的条件下的相对密度为1.10~1.15的清膏,自然冷却至室温,加入乙醇至溶液中含醇量为70%~80%,而后搅拌均匀,再静置20~30h,得混合溶液;
3)将混合溶液过滤,滤液回收乙醇并浓缩至80℃的条件下的相对密度为1.20~1.25的清膏,然后加水至1800~2000mL,搅拌均匀,在温度为4~7℃的条件下冷藏处理90~100h,过滤,滤液加入30g蔗糖、1g防腐剂,然后加水至1800~2000mL,搅拌均匀,即得。
实施例3:
1)将110g石膏、用水煎煮0.5h,然后加入110g板蓝根、60g芦根、90g地黄、150g石菖蒲、110g广藿香、70g连翘、25g忍冬藤、110g白芷、90g胖大海、7g蒲公英、9g罗汉果、11g金银花、55g桔梗、50g葛根、55荆芥、10g川贝、7g甘草、55g柴胡、15g防风再用水煎煮3次,每次1h,而后合并煎液,得混合煎液;
2)将混合煎液过滤,而后减压浓缩至80℃的条件下的相对密度为1.10~1.15的清膏,自然冷却至室温,加入乙醇至溶液中含醇量为70%~80%,而后搅拌均匀,再静置20~30h,得混合溶液;
3)将混合溶液过滤,滤液回收乙醇并浓缩至80℃的条件下的相对密度为1.20~1.25的清膏,然后加水至1800~2000mL,搅拌均匀,在温度为4~7℃的条件下冷藏处理90~100h,过滤,滤液加入50g蔗糖、3g防腐剂,然后加水至1800~2000mL,搅拌均匀,即得。
应用例:
1.临床资料:
一般资料所选病例均为本院门诊及住院病人。
随机分为治疗组52例。其中男30例,女22例。年龄8月-1岁5例,1-2岁18例,3-6岁29例。
对照组48例。年龄8月-1岁l0例,1-2岁11例,3-6岁27例。两组一般资料对比,差别无统计学意义,具有可比性。
诊断标准均为单独发生,无全身症状的疱疹性咽颊炎。患儿发热、咽部疼痛、拒食、流涎。体格检查:咽部充血,软腭、咽腭弓等处有直径2-4mm大小的疱疹,周边有红晕或见浅表溃疡。实验室检查:血常规检查:白细胞总数正常或下降。C反应蛋白正常。
2.治疗方法:
治疗组:服用本发明药物制成的口服液,每天2次,1岁以内服3ml,1-3岁服5ml,3岁以上服10ml。
对照组:利巴韦林10mg/(kg·d)静脉滴注。若合并感染加用抗菌药物。两组均以5-7天为一疗程。
3.治疗效果:
疗效评价观察指标:以患儿治疗前后发热、咽痛、流涎等症状程度及疱疹数目进行对比。
显效:发热、咽痛、流涎等症状完全消失,单个疱疹消失,多发性疱疹减少一半以上。
有效:发热、咽痛、流涎等症状减轻,单个疱疹缩小,多发性疱疹减少。
无效:症状、体征均无改善。
4.两组结果对比:
组别 | 总人数 | 显效 | 有效 | 无效 | 总有效率 |
治疗组 | 52 | 40 | 10 | 2 | 96.15% |
对照组 | 48 | 14 | 17 | 17 | 64.58% |
由对比表可以看出,本发明的中药口服液用药量小、见效快、无副作用,避免了小儿静脉注射的痛苦,并有效治愈了病情。
Claims (5)
1.一种治疗小儿疱疹性咽颊炎的中药口服液,其特征在于:由100-120g板蓝根、100-120g石膏、50-80g芦根、80-100g地黄、150-160g石菖蒲、100-120g广藿香、60-80g连翘、20-30g忍冬藤、100-120g白芷、80-100g胖大海、60-80g蒲公英、80-100g罗汉果、100-120g金银花、50-60g桔梗、30-60g葛根、50-60g荆芥、10-15g川贝、60-80g甘草、50-60g柴胡、10-20g防风、30-60g蔗糖、1-5g防腐剂加入水中制成;防腐剂为羟苯甲腊或羟苯乙脂。
2.如权利要求1所述的一种治疗小儿疱疹性咽颊炎的中药口服液,其特征在于:由100g板蓝根、100g石膏、80g芦根、100g地黄、150g石菖蒲、100g广藿香、80g连翘、20g忍冬藤、120g白芷,80g胖大海、60g蒲公英、100g罗汉果、120g金银花、50g桔梗、30g葛根、60g荆芥、10g川贝、80g甘草、50g柴胡、10g防风、60g蔗糖、5g防腐剂加入水中制成。
3.如权利要求1所述的一种治疗小儿疱疹性咽颊炎的中药口服液,其特征在于:由120g板蓝根、120g石膏、50g芦根、80g地黄、160g石菖蒲、100g广藿香、60g连翘、30g忍冬藤、100g白芷、80g胖大海、80g蒲公英、80g罗汉果、100g金银花、60g桔梗、60g葛根、50g荆芥、15g川贝、60g甘草、60g柴胡、20g防风、30g蔗糖、1g防腐剂加入水中制成。
4.如权利要求1所述的一种治疗小儿疱疹性咽颊炎的中药口服液,其特征在于:由110g板蓝根、110g石膏、60g芦根、90g地黄、150g石菖蒲、110g广藿香、70g连翘、25g忍冬藤、110g白芷、90g胖大海、7g蒲公英、9g罗汉果、11g金银花、55g桔梗、50g葛根、55荆芥、10g川贝、7g甘草、55g柴胡、15g防风、50g蔗糖、3g防腐剂加入水中制成。
5.制备如权利要求1-3任一所述中药口服液的方法,其特征在于:包括如下步骤:
1)将石膏用水煎煮0.5h,然后加入其他中药再用水煎煮3次,每次1h,而后合并煎液,得混合煎液;
2)将混合煎液过滤,而后减压浓缩至80℃的条件下的相对密度为1.10~1.15的清膏,自然冷却至室温,加入乙醇至溶液中含醇量为70%~80%,而后搅拌均匀,再静置20~30h,得混合溶液;
3)将混合溶液过滤,滤液回收乙醇并浓缩至80℃的条件下的相对密度为1.20~1.25的清膏,然后加水至1800~2000mL,搅拌均匀,在温度为4~7℃的条件下冷藏处理90~100h,过滤,滤液加入防腐剂和糖,然后加水至1800~2000mL,搅拌均匀,即得。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510551141.7A CN105125909B (zh) | 2015-08-31 | 2015-08-31 | 一种治疗小儿疱疹性咽颊炎的中药口服液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510551141.7A CN105125909B (zh) | 2015-08-31 | 2015-08-31 | 一种治疗小儿疱疹性咽颊炎的中药口服液及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105125909A true CN105125909A (zh) | 2015-12-09 |
CN105125909B CN105125909B (zh) | 2018-12-25 |
Family
ID=54711720
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510551141.7A Active CN105125909B (zh) | 2015-08-31 | 2015-08-31 | 一种治疗小儿疱疹性咽颊炎的中药口服液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105125909B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106106919A (zh) * | 2016-06-18 | 2016-11-16 | 广州聚注专利研发有限公司 | 一种含有黄皮叶的保健茶饮料及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104189602A (zh) * | 2014-09-19 | 2014-12-10 | 李诗标 | 一种治疗手足口病的药物组合物 |
CN104225516A (zh) * | 2014-08-15 | 2014-12-24 | 曲凤元 | 一种治疗小儿疱疹性咽颊炎的中药 |
-
2015
- 2015-08-31 CN CN201510551141.7A patent/CN105125909B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104225516A (zh) * | 2014-08-15 | 2014-12-24 | 曲凤元 | 一种治疗小儿疱疹性咽颊炎的中药 |
CN104189602A (zh) * | 2014-09-19 | 2014-12-10 | 李诗标 | 一种治疗手足口病的药物组合物 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106106919A (zh) * | 2016-06-18 | 2016-11-16 | 广州聚注专利研发有限公司 | 一种含有黄皮叶的保健茶饮料及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105125909B (zh) | 2018-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104667222A (zh) | 一种养胃健脾的中药 | |
CN104258431B (zh) | 一种制备b超助影剂的中药组合物 | |
CN101020012A (zh) | 一种治疗风湿、类风湿疼痛的外用中药液体制剂的配方 | |
CN101085308B (zh) | 一种口服治疗乳腺癌的中药汤剂 | |
CN102526280B (zh) | 一种治疗口腔溃疡的中药组合物 | |
CN106138846B (zh) | 一种治疗更年期综合征的中药组合物及其制剂和应用 | |
CN102631512A (zh) | 一种治疗慢性结肠炎的中药组合物 | |
CN102579807B (zh) | 一种治疗口腔溃疡的中药组合物 | |
CN103908511B (zh) | 一种治疗软骨瘤的中药药丸及制备方法 | |
CN106362111A (zh) | 一种改善痰湿体质的药物组合物和一种药砖及其制备方法 | |
CN105381411A (zh) | 一种治疗癫痫的药物及其制备方法 | |
CN105396103A (zh) | 一种快速治疗脂肪肝的制剂 | |
CN104352955A (zh) | 一种治疗肺炎的中药 | |
CN105125909A (zh) | 一种治疗小儿疱疹性咽颊炎的中药口服液及其制备方法 | |
CN106668646A (zh) | 一种治疗鸡产蛋量下降的中药物 | |
CN103301304A (zh) | 一种治疗乳腺增生的中药组合物 | |
CN105056126A (zh) | 一种治疗子宫肌瘤的中药组合物 | |
CN104888093A (zh) | 一种治疗小儿腹泻的脐贴 | |
CN104667158A (zh) | 一种治疗病毒性心肌炎的药物 | |
CN103536705B (zh) | 一种治疗结肠炎的中药组合物 | |
CN105327299A (zh) | 一种用于治疗原发性血小板减少紫癜的药物 | |
CN104906449A (zh) | 一种治疗子宫颈炎的中药 | |
CN105456651A (zh) | 用于治疗由血虚失荣、瘀血阻滞引起的脱发的药物 | |
CN104161846A (zh) | 治疗肾盂肾炎的中药制剂 | |
CN104208490A (zh) | 一种治疗肺炎的中草药散剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240326 Address after: 730314 No. 2299 middle section of Kunlun Mountains Avenue, Lanzhou New District, Lanzhou, Gansu. Patentee after: LANZHOU HOLYSHINE PHARMACEUTICAL CO.,LTD. Country or region after: China Address before: 266300 people's Hospital of Jiaozhou City, Qingdao City, Shandong Province Patentee before: Wang Hong Country or region before: China |